BTI
RDY icon

Blue Trust Inc’s Dr. Reddy's Laboratories RDY Stock Holding History

Blue Trust Inc’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Sell
31,123
-1,514
-5% -$20.4K ﹤0.01% 522
2026
Q1 		$452K Buy
32,637
+358
+1% +$4.98K 0.01% 510
2025
Q4 		$453K Sell
32,279
-587
-2% -$8.23K 0.01% 519
2025
Q3 		$459K Sell
32,866
-15,882
-33% -$229K 0.01% 520
2025
Q2 		$733K Buy
48,748
+6,745
+16% +$96.3K 0.01% 357
2025
Q1 		$554K Buy
42,003
+8,918
+27% +$123K 0.01% 388
2024
Q4 		$522K Sell
33,085
-29,150
-47% -$438K 0.01% 369
2024
Q3 		$948K Buy
62,235
+24,475
+65% +$394K 0.01% 287
2024
Q2 		$554K Buy
37,760
+19,370
+105% +$278K 0.01% 346
2024
Q1 		$270K Buy
18,390
+1,500
+9% +$21.9K ﹤0.01% 420
2023
Q4 		$227K Buy
16,890
+7,365
+77% +$98.5K ﹤0.01% 414
2023
Q3 		$120K Buy
9,525
+4,370
+85% +$59.1K ﹤0.01% 574
2023
Q2 		$58K Sell
5,155
-5,305
-51% -$61.9K ﹤0.01% 654
2023
Q1 		$108K Buy
10,460
+3,450
+49% +$37.2K ﹤0.01% 742
2022
Q4 		$73K Buy
7,010
+2,115
+43% +$22.8K ﹤0.01% 774
2022
Q3 		$54K Buy
4,895
+4,515
+1,188% +$48.1K ﹤0.01% 727
2022
Q2 		$4K Buy
+380
New +$4.13K ﹤0.01% 1518

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Blue Trust Inc's RDY Position: Q2 2026 in Review

Blue Trust Inc reduced its Dr. Reddy's Laboratories (RDY) stake by 4.6% in Q2 2026, selling an estimated $20.4K and leaving 31,123 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Blue Trust Inc first reported a position in RDY in Q2 2022 and has held it in 17 quarters since. The position peaked at $948K in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Blue Trust Inc held 31,123 shares of Dr. Reddy's Laboratories worth $451K as of Q2 2026.
  • Blue Trust Inc sold 1,514 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $20.4K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #522 holding.
  • Blue Trust Inc first reported a position in Dr. Reddy's Laboratories in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Dr. Reddy's Laboratories position peaked at $948K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.